| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:1738.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, and Philips Medical Systems (B.S.), Hamburg, Germany.
Correspondence to Eike Nagel, MD, Internal Medicine/Cardiology, German Heart Institute, Augustenburger Platz 1, D-13353 Berlin, Germany. E-mail eike.nagel{at}dhzb.de
| Abstract |
|---|
|
|
|---|
Methods and Results Thirty-eight patients after successful PTCA and stent deployment were included. CFVR was measured perpendicular to the artery distal to the stent using phase-contrast velocity quantification at rest and during adenosine-stimulated hyperemia with a 1.5T MR tomograph (ACS NT, Philips). Measurements were repeated after 3 months and compared with invasive coronary angiography. In 18 patients, additional invasive Doppler flow measurements were obtained. CFVR could be determined in 29 of 38 (76%) of the patients. After 3 months, significant differences were obtained between coronary arteries with and without restenosis. Using a threshold of 1.2, a sensitivity of 83% with a specificity of 94% was achieved for
75% stenoses. CFVR with CMR was similar to Doppler results (r=0.87), with a mean relative difference of 7.5%.
Conclusions In patients with preserved coronary microcirculating vasoreactivity that are suitable for MR coronary angiography and flow assessments, CMR measures of coronary blood flow velocities reserve may be used to detect in-stent restenosis.
Key Words: magnetic resonance imaging coronary disease angiography restenosis
| Introduction |
|---|
|
|
|---|
The aims of the present study were to evaluate the feasibility of MR phase-contrast flow measurements for the noninvasive assessment of intracoronary blood flow velocity reserve after stent deployment, to determine its accuracy for the detection of restenosis, and to compare the results to invasive Doppler flow measurements.
| Methods |
|---|
|
|
|---|
Coronary Angiography
All patients underwent biplane left-sided cardiac catheterization and selective coronary angiography in Judkins technique before and after stent deployment as well as after 3 months, as routinely done in our institution. Coronary stenoses were filmed in the center of the field from multiple projections, avoiding as much as possible overlap of side branches and foreshortening of relevant coronary stenoses. Quantitative assessment was performed using quantitative coronary angiography (QANSAD QCA System; ARRI Munich) by an experienced observer blinded to the results of the MR examination. Coronary arteries were graded as having a 50% to 74% cross-sectional area reduction or a
75% cross-sectional area reduction with respect to prestenotic segment area.
Invasive Doppler Flow Measurements
In 18 patients, peak flow velocity measurements were obtained using a 0.014-inch Doppler velocity wire (Cardiometrics) during follow-up angiography. The wire was positioned 10 mm distal to the stent, and measurements were obtained at rest and during adenosine infusion of 0.14 mg/kg body weight per min via an antecubital vein for a maximum of 6 minutes. Coronary flow velocity reserve (CFVR) was calculated as the ratio of peak flow velocity during maximal hyperemia to baseline peak flow velocity.
Magnetic Resonance Flow Measurements
Image Acquisition
Patients were examined with a 1.5-Tesla whole-body MR tomograph (ACS NT, Philips) using a dedicated phased-array cardiac surface coil (5 elements) 24 hours and 3 months after stent deployment. After a rapid survey, transversal slices were acquired in breath hold technique during expiration to localize the coronary arteries. In these images, the position of the stent could be easily determined because of the artifacts induced by the stents. Double-angulated slices, which included a long segment of the vessel, were acquired (Figure 1). In vitro measurements of stent artifacts yielded a maximal artifact size exceeding stent size by 10 mm (5 mm each side).1 In vitro measurements in our institution showed that flow measurements should not be influenced if their distance to the stent doubles the distance of the visible artifact. Thus, measurements were performed perpendicular to the vessel, 5 mm distal to the stent artifact (Figure 1) at rest and during an adenosine-induced hyperemia, applying the identical stress protocol as for the invasive procedure. This position should be very close to the position of the invasive Doppler measurements, because it is well defined by the stent position.
|
A segmented k-space phase-contrast turbo gradient echo technique with symmetric bipolar gradient pulses3 with a spatial resolution of 1x0.9x4 mm and a temporal resolution of 45 ms (TE/TR/flip: 6.9 ms/11.5 ms/40°; 4 k-lines per phase per heartbeat; velocity encoding: 100 cm/s at rest and 200 cm/s during stress) was used. To improve signal to noise ratio, 2 acquisitions were performed and the resulting signal was averaged. Breathing artifacts were reduced by prospective navigator gating with adaptive motion correction (gating window: 5 mm). The imaging sequence was adapted to the actual diaphragmatic position in real time. This correction was performed by shifting the craniocaudal imaging position by 30% of the actual diaphragmatic offset.4
Image Analysis
Readers blinded to each technique performed analysis of the MR images and Doppler results. Regions of interest with an area of 2x2 voxels were placed in the center of the vessel on the flow images for each cardiac phase. The region of interest was shifted in each phase to include the 4 voxels with the fastest average flow velocity. The average flow velocity (cm/s) of this region of interest was determined for each phase. To correct for cardiac through plane motion and eddy currents, a region of interest was placed on adjacent myocardium and the velocity of myocardial through plane motion was determined and subtracted from the intracoronary flow values. The highest value was used for the determination of peak flow velocity. CFVR was calculated as the ratio of peak flow velocity during hyperemia to the peak flow velocity at rest. For the assessment of diagnostic accuracy for the detection of stenoses
75% cross-sectional area reduction, a threshold value of 1.5 was used.
Statistical Analysis
All data are given as mean±1 SD. ANOVA was used to detect differences between groups of different stenosis severity. Significance was tested with a Scheffé procedure. A 2-tailed Students t test was used to calculate statistical differences, with P<0.05 being regarded as statistically significant. Comparison between results from Doppler and CMR was performed using the Bland-Altman analysis and a linear regression analysis.
| Results |
|---|
|
|
|---|
|
|
Invasive Procedures
Stent placement was successfully performed in 25 LAD and 13 RCA vessels ranging from 1.40 to 3.9 mm distal reference diameter (mean, 2.50 mm). At 3 months of follow-up, 14 vessels (37%) showed a restenosis of
75% cross-sectional area reduction in the invasive coronary angiography. Ten vessels (26%) showed a 50% to 74% cross-sectional area reduction.
MR Measurements
In 29 of the 38 patients (76%), adequate flow measurements could be obtained distal to the stent. In 4 patients no adequate placement of the imaging plane without a major vessel branch leaving the target vessel could be obtained, in 4 patients image quality did not allow to detect a flow signal, and in 1 patient severe shortness of breath developed during adenosine infusion. Examination time was
45 to 60 minutes (3 to 5 minutes for each flow measurement depending on navigator efficiency).
Maximal flow velocity at rest was 66±13 cm/s (LAD) and 37±9 cm/s (RCA). During adenosine stimulation, maximal flow velocity was 121±30 cm/s (LAD) and 70±15 cm/s (RCA), resulting in a mean CFVR of 1.82±0.22 (LAD) and 1.90±0.4 (RCA) (Figure 1).
At follow-up, CFVR of 1.78±0.16 was found in vessels without coronary artery stenosis, 1.46±0.22 in vessels with 50% to 74% cross-sectional area reduction, and 1.10±0.22 in vessels with
75% cross-sectional area reduction (P between all groups <0.05).
The diagnostic accuracy of CFVR measurements is shown in Table 3. No overlap was found between vessels without (<50% cross-sectional area reduction) and vessels with
75% cross-sectional area reduction; however, vessels with 50% to 74% cross-sectional area reduction showed overlap with both other groups (Figure 2).
|
|
Comparison of MR and Doppler
Flow velocity measurements with the Doppler flow wire resulted in 79±20 cm/s (LAD) and 40±6 cm/s (RCA). After adenosine stimulation, flow velocities were 147±36 cm/s (LAD) and 80±21 cm/s (RCA), resulting in a mean CFVR of 1.88±0.25 (LAD) and 2.0±0.48 (RCA).
Regression analysis for CFVR determined with CMR and Doppler resulted in a slope of 0.74 (r=0.89) at rest and 0.80 (r=0.93) during stress (Bland-Altman analysis in Figure 4). For CFVR, the correlation yielded a slope of 1.04 (r=0.87) (Bland-Altman analysis in Figure 3). The mean relative error of MR CFVR measurements versus Doppler was 7.5±5.0%.
|
| Discussion |
|---|
|
|
|---|
In-stent restenoses are a major problem, and innumerable attempts have been suggested to avoid this drawback. Because all noninvasive tests, such as ECG,5 SPECT,6 or EBCT,7 are relatively insensitive and nonspecific for the detection of restenoses, many of these patients undergo invasive coronary angiography to identify restenosis in recurrent chest pain. In some centers, invasive routine follow-up is performed after stent placement to be able to treat restenosis at an early time point. With CMR, the noninvasive imaging of the proximal and medial coronary arteries becomes more and more feasible; however, the artifacts after stent placement prohibit CMR imaging within the stent. It has been shown to be safe and feasible to measure flow
1 cm distal to the stent using phase-contrast techniques,8,9 which have been well established and validated for larger vessels.1012 Good accuracy and reproducibility of MR flow measurements have also been shown in small-caliber phantoms or coronary arteries in animals,1315 with close correlations with intravascular and extravascular Doppler techniques despite the complexity of such measurements in small and rapidly moving vessels. Previous investigators have used breath hold techniques to reduce breathing artifacts, which limits the maximal scan duration to 30 seconds or less.1620 Whereas with this approach data can be acquired rapidly and breathing motion artifacts can be well suppressed, a low temporal resolution has to be accepted. Accordingly, in these previous studies the number of heart phases ranged from 1 to 621 and was only increased by calculating interleaved data (view sharing).22 In 1993, Edelman et al16 demonstrated for the first time that blood flow velocity can be determined noninvasively in human coronary arteries with MR; however, only a single middiastolic value was obtained. In an animal study, Clarke et al23 were able to demonstrate that an increase of the temporal resolution from 1 to 6 frames per heartbeat led to a reduction of the limits of agreement between MR and Doppler from 45 to 10 mL/min. However, no additional improvement of temporal resolution was tested at that time to avoid overly long breath holding. Since then, the technique has been additionally optimized and compared with invasive measurements of flow or flow reserve.17,19,21,24,25 Hundley et al26 have shown a sensitivity and specificity of 100% and 83% for the detection of significant coronary artery stenoses of the proximal and middle left anterior descending coronary artery using a breath hold technique with a temporal resolution of 112 to 168 ms. In another study of 17 patients, using the same technique they showed that in patients with recurrent chest pain 6 weeks after a successful percutaneous intervention (8 with stent deployment), the assessment of flow reserve with phase-contrast CMR can be used to identify a 70% luminal diameter narrowing at the site of the intervention (sensitivity 100%; specificity 89%) compared with QCA.27 In this study, however, an inhomogeneous patient population was included, eg, a large percentage of patients with myocardial infarction or hypertension. In addition, only patients with proximal and middle left coronary artery disease and 1 patient with right coronary artery disease were included. Especially in the right coronary artery, rapid in-plane motion is to be expected, and a temporal resolution below 25 ms is required to accurately measure coronary artery flow in the RCA with MR methods.28 Because the breath hold techniques applied in previous studies resulted in a temporal resolution of <100 ms, the investigators limited themselves to the LAD, except for 1 reported case of flow measurements in the RCA.17,19,26,27 With this study we extend MR flow measurements to the RCA, which was possible by using shorter acquisition times per heartbeat. Even though we did not reach the temporal resolution set forth by Hofman et al,28 we were able to come very close to this value, thus minimizing motion-induced blurring and inaccuracies. A second advantage of the navigator-gating technique used is the elimination of the need of breath holding for up to 30 seconds. Such breath holds are difficult for many patients, especially with adenosine stimulation, and may influence coronary artery flow due to the Valsalva maneuver.
This study extends previous observations in several aspects. First, we concentrated on a subgroup of patients, which presents a major problem for optimal treatment and follow-up, namely patients after stent deployment. In this group, noninvasive visualization of the coronary arteries with MR or CT imaging is not possible in the stented segments. From a methodological view, MR coronary flow measurements are more difficult in this group, because the exact coronary segment for flow measurements is predefined by the stent, not by the MR examiner. This predefined measurement position, however, allows a more accurate comparison of MR and Doppler flow wire. Second, we included patients with stents in the left or right coronary artery, thus extending the potential application of MR flow measurements. Third, the position of the flow measurement was not predefined by the inclusion criteria but by the clinical decision on where to place the stent. Thus, the present study covers the full range of vessel diameters usually stented in clinical practice from 1.4 to 3.9 mm.
In the present study, we show that an in-stent coronary artery cross-sectional area reduction of
50% can be detected with an accuracy of 86% and a high positive predictive value of 94%. For cross-sectional area reductions of
75%, a diagnostic accuracy of 90% was reached. The slightly reduced sensitivity of 85% for the detection of 50% area reduction may reflect the fact that flow does not measure morphology but function and such luminal area reductions may not have any hemodynamic relevance in some cases.
With CMR, an underestimation of coronary flow velocity was found compared with Doppler. This observation has also been reported from other authors.19,29,30 It can be mainly attributed to the lower temporal resolution (and, thus, the highest flow velocity during the cardiac cycle is missed) and the lower spatial resolution (and, thus, an average flow velocity of a small region of interest, rather than the fastest flow velocity within the vessel, is determined) compared with intravascular Doppler. However, underestimation was systematic and thus can be corrected for. In addition, the calculation of flow velocity reserve rather than the use of absolute values led to similar results for CMR and Doppler.
Mild but significantly higher heart rates were found during the MR stress study in comparison with the Doppler examination. Because exactly the same stress protocol was used for both examinations, this can either be explained by psychological reasons (with the patient more stressed within the MR scanner, leading to a tendency of higher heart rates at rest) or the fact that the MR scan was done before the invasive procedure and, thus, the patient was more accustomed to adenosine during the invasive measurement. However, the mean difference was 5 beats per minute, which should only have a very limited influence on coronary artery flow.
Limitations
A general limitation applies to the concept of coronary flow reserve measurements, because these measurements are not applicable to patients with abnormal coronary flow at rest. This includes patients with myocardial infarction, left ventricular hypertrophy, microvessel disease, cardiomyopathy, or severe valvular heart disease or patients in the first weeks after coronary intervention or after bypass grafting. In our study, these patients were excluded.
A technical limitation applies to the technique used. To achieve high spatial and temporal resolution, long scan times of 3 to 5 minutes for each flow measurement, depending on navigator efficiency, were accepted, which prohibited the assessment of more than one coronary artery during one adenosine stress, because this stress test is limited to a maximum duration of 6 minutes. In addition, planning of image acquisition and image analysis required >2 hours, which prohibited the routine clinical use of the technique at the current time.
Conclusions
In conclusion, MR flow measurements allow the noninvasive determination of coronary blood flow velocities after stent deployment similar to Doppler flow measurements. This technique can be used to detect in-stent restenosis with a diagnostic accuracy of 86% for
50% cross-sectional area reduction and 90% for
75% cross-sectional area reduction in patients with preserved vasoreactivity.
| Footnotes |
|---|
Received November 13, 2002; revision received January 16, 2003; accepted January 16, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. A. Bluemke, S. Achenbach, M. Budoff, T. C. Gerber, B. Gersh, L. D. Hillis, W. G. Hundley, W. J. Manning, B. F. Printz, M. Stuber, et al. Noninvasive Coronary Artery Imaging: Magnetic Resonance Angiography and Multidetector Computed Tomography Angiography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young Circulation, July 29, 2008; 118(5): 586 - 606. [Full Text] [PDF] |
||||
![]() |
E. Spuentrup, A. Ruebben, A. Mahnken, M. Stuber, C. Kolker, T. H. Nguyen, R. W. Gunther, and A. Buecker Artifact-Free Coronary Magnetic Resonance Angiography and Coronary Vessel Wall Imaging in the Presence of a New, Metallic, Coronary Magnetic Resonance Imaging Stent Circulation, March 1, 2005; 111(8): 1019 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terashima, C. H. Meyer, B. G. Keeffe, E. J. Putz, E. de la Pena-Almaguer, P. C. Yang, B. S. Hu, D. G. Nishimura, and M. V. McConnell Noninvasive assessment of coronary vasodilation using magnetic resonance angiography J. Am. Coll. Cardiol., January 4, 2005; 45(1): 104 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Moreno and V. Fuster The year in atherothrombosis J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2099 - 2110. [Full Text] [PDF] |
||||
![]() |
L. P. Salm, J. J. Bax, H. W. Vliegen, S. E. Langerak, P. Dibbets, J. W. Jukema, H. J. Lamb, E. K.J. Pauwels, A. de Roos, and E. E. van der Wall Functional significance of stenoses in coronary artery bypass grafts: Evaluation by single-photon emission computed tomography perfusion imaging, cardiovascular magnetic resonance, and angiography J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1877 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |